The current and future disease burden of chronic hepatitis C virus infection in Egypt.
about
Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010Hepatitis C Virus in North Africa: An Emerging ThreatHepatitis C in Egypt - past, present, and futureNational treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care.Hepatitis C infection in Egypt: prevalence, impact and management strategies.Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies.Management of hepatitis C genotype 4 in the directly acting antivirals era.The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment.Hepatitis C virus and non-Hodgkin's lymphomas: A minireview.HCV management in resource-constrained countries.Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt.Evaluation of TRAIL receptor 1 (DR4) Polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.APASL consensus statements and recommendation on treatment of hepatitis C.Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement.Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patientsTowards hepatitis C virus elimination: Egyptian experience, achievements and limitations
P2860
Q27000368-E4E6233F-5203-437F-96A0-A23A4779743DQ28069590-8FA1667E-34CB-4247-A7FF-1105BBC29E4FQ28354329-CAA552AE-FDD7-4E45-9E83-7690FB44A478Q30238676-3509F996-3F55-4CC4-861E-59409086E196Q33713718-D5D0958D-7EE1-4BB2-BF81-88D2AA6A0F13Q37279353-4202ECAB-AC5A-4FCF-B9CC-29641E8FC645Q37312151-92C0BD6A-1DCF-43C9-B18A-6C2D92E2E5C9Q37486425-967994A1-EFC9-48F4-BCF4-6B48E7583AF5Q37610899-E48E3D7A-37A0-4181-9458-0FE6D657695FQ38372939-34DAD06F-E927-4244-BD24-6C541845F9DDQ38842781-C70EBFDA-E5DE-4379-8B44-29D00B6CD8F2Q38992672-6A85B03E-6693-400F-83AD-68DF7D4F12C6Q41924906-95E34C50-2974-42D7-83E8-5FE30C793646Q42400012-CD4DB782-72E2-4581-8A1E-136D68C3A8E0Q45325830-B0AC1619-EE4C-4791-A205-B1A67CBA92A6Q57494344-7D7898A4-BA43-47AC-A753-0C2C8D0EE501Q57815114-13B481E9-08AA-4C49-991C-C31449C61E2B
P2860
The current and future disease burden of chronic hepatitis C virus infection in Egypt.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The current and future disease burden of chronic hepatitis C virus infection in Egypt.
@en
type
label
The current and future disease burden of chronic hepatitis C virus infection in Egypt.
@en
prefLabel
The current and future disease burden of chronic hepatitis C virus infection in Egypt.
@en
P2093
P50
P1476
The current and future disease burden of chronic hepatitis C virus infection in Egypt.
@en
P2093
Ayman Yosry
Gamal Esmat
Manal Hamdy El-Sayed
Waheed Doss
P356
10.1016/J.AJG.2014.04.003
P577
2014-06-06T00:00:00Z